April 30, 2021
Video
Analysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
April 23, 2021
Video
Expert discussion on the recent topline results released for vutrisiran in the HELIOS-A trial.
April 23, 2021
Video
Discussion on the role of TTR protein stabilizers and gene silencers for treating hereditary ATTR amyloidosis.
April 16, 2021
Video
Clinicians elaborate on key trial data revealed through the APOLLO and NEURO-TTR studies in hereditary ATTR amyloidosis.
April 16, 2021
Video
Treatment overview of hereditary ATTR amyloidosis and considerations for using newer therapies such as patisiran or inotersen in appropriate patients.
April 09, 2021
Video
The use of mass spectrometry is the gold standard in amyloid proteins.
April 09, 2021
Video
Various types of biopsies to diagnosis hereditary ATTR amyloidosis are discussed.
April 02, 2021
Video
Expert panelists provide recommendations for gene panel testing with genetic counseling for evaluation of patients with hereditary ATTR amyloidosis.
April 02, 2021
Video
Diagnostic criteria commonly used to ensure an accurate diagnosis of hereditary ATTR amyloidosis is dissected.
March 26, 2021
Video
Panelists suggest how to differentiate between diabetic neuropathy and ATTR amyloidosis.
Serum Neurofilament Light Poses as Critical Biomarker During Ataxic, Preataxic Stages of Spinocerebellar Ataxias
Connecting ALS: How New Drug Coverage Decisions Are Made
NeuroVoices: Mark Lew, MD, on the Validation of Tears as a Biomarker for Parkinson Disease
AlzoSure Predict Test Shows Predictive Ability for Alzheimer Disease Years Prior to Diagnosis